Viewing Study NCT07245628


Ignite Creation Date: 2025-12-26 @ 11:14 AM
Ignite Modification Date: 2026-01-13 @ 11:17 PM
Study NCT ID: NCT07245628
Status: RECRUITING
Last Update Posted: 2025-11-24
First Post: 2025-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Self-Adjusted Nitrous Versus Placebo During Office Vasectomy
Sponsor: Alexandra J. Berger Eberhardt, MD
Organization:

Study Overview

Official Title: A Single-Blind Randomized Placebo Controlled Trial of Self-Adjusted Nitrous Oxide During Office Vasectomy
Status: RECRUITING
Status Verified Date: 2025-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to see if nitrous oxide is safe and effective to use during during vasectomies performed in a clinic/in-office setting.

This trial will compare self-administered nitrous oxide versus a placebo (oxygen) during office vasectomy.

The main questions it aims to answer are:

* Whether self-administered low dose (20-45%) nitrous oxide (SANO) reduces intraoperative anxiety and catastrophizing during office vasectomy.
* To examine whether SANO reduces intraoperative pain or alters procedure duration, the rate of adverse events, or urologists' perception of ease and patient tolerance of the procedure.

Participants will be asked to complete multiple surveys pre-procedure, intra-procedure, and post-procedure.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: